Colgate-Palmolive director awarded stock and options

Colgate-Palmolive director Christopher S. Boerner reported equity compensation awards.

Rhea-AI Filing Summary

Colgate-Palmolive director Christopher S. Boerner reported equity compensation awards. He received an annual director stock grant of 1,383 shares of common stock under the company’s incentive compensation plan, leaving him with 1,383 common shares directly owned after the award.

He was also granted a stock option for 2,020 shares of common stock with an exercise price of $86.74 per share, expiring on May 11, 2034. The option becomes exercisable in equal annual installments over three years, beginning on the first anniversary of the May 11, 2026 grant date. These are compensation-related awards rather than open-market purchases or sales.

Insider Trade Summary

Grant/Award: 3,403 shares

Grant/Award 2 txns

Insider BOERNER CHRISTOPHER S.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	2,020	$0.00	$0.00
Grant/Award	Common Stock	1,383	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 2,020 contracts (Direct); Common Stock — 1,383 shares (Direct)

Footnotes (3)

1. F1. Annual director stock grant under the issuer's incentive compensation plan.
2. F2. Annual director stock option grant under the issuer's incentive compensation plan.
3. F3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

Key Figures

Director stock grant: 1,383 shares Common shares held: 1,383 shares Stock option grant size: 2,020 shares +3 more

6 metrics

Director stock grant 1,383 shares Annual director stock grant of common stock

Common shares held 1,383 shares Total common stock directly owned after grant

Stock option grant size 2,020 shares Annual director stock option covering common stock

Option exercise price $86.74 per share Stock option (right to buy) strike price

Option expiration May 11, 2034 Stock option expiration date

Vesting period 3 years Equal annual installments starting first anniversary of May 11, 2026 grant date

Key Terms

incentive compensation plan, Annual director stock grant, Stock Option (Right to Buy), exercisable in equal annual installments

4 terms

incentive compensation plan financial

"Annual director stock grant under the issuer's incentive compensation plan."

An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.

Annual director stock grant financial

"Annual director stock grant under the issuer's incentive compensation plan."

Stock Option (Right to Buy) financial

"Stock Option (Right to Buy)"

exercisable in equal annual installments financial

"Option becomes exercisable in equal annual installments over three years"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Colgate-Palmolive (CL) director Christopher S. Boerner report in this Form 4?

Christopher S. Boerner reported receiving equity compensation awards, not open-market trades. He was granted 1,383 shares of common stock and a stock option for 2,020 shares under Colgate-Palmolive’s incentive compensation plan as part of his annual director compensation.

How many Colgate-Palmolive shares did Christopher S. Boerner receive in the latest grant?

He received 1,383 shares of Colgate-Palmolive common stock as an annual director stock grant. Following this award, his reported direct common stock holdings total 1,383 shares, reflecting the compensation-related nature of this transaction rather than a market purchase.

What are the key terms of Christopher S. Boerner’s new Colgate-Palmolive stock option?

He was granted a stock option covering 2,020 shares of Colgate-Palmolive common stock at an exercise price of $86.74 per share. The option expires on May 11, 2034 and vests in equal annual installments over three years starting one year after the grant date.

Is Christopher S. Boerner’s Form 4 for Colgate-Palmolive a stock purchase or compensation award?

The filing reflects compensation awards, not an open-market stock purchase. It records an annual director stock grant of 1,383 shares and an annual stock option grant for 2,020 shares, both made under Colgate-Palmolive’s incentive compensation plan.

How does the vesting schedule work for Christopher S. Boerner’s Colgate-Palmolive stock option grant?

The option becomes exercisable in three equal annual installments. Vesting begins on the first anniversary of the May 11, 2026 grant date, so one-third vests each year over three years, aligning with typical multi-year director compensation structures.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/13/2026 - 04:46 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BOERNER CHRISTOPHER S.

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NEW YORK 10022

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/11/2026		A(1)		1,383	A	$0.0000	1,383	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$86.74	05/11/2026		A(2)		2,020		(3)	05/11/2034	Common Stock	2,020	$0.0000	2,020	D

Explanation of Responses:

1. Annual director stock grant under the issuer's incentive compensation plan.

2. Annual director stock option grant under the issuer's incentive compensation plan.

3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.

	/s/ Kristine Hutchinson, Attorney-in-Fact	05/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)